Organovo Holdings Inc (ONVO)

NASDAQ
Currency in USD
0.350
+0.008(+2.93%)
Closed
After Hours
0.360+0.010(+2.857%)
ONVO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 3 days
Fair Value
Day's Range
0.3350.350
52 wk Range
0.3151.740
Key Statistics
Edit
Prev. Close
0.342
Open
0.335
Day's Range
0.335-0.35
52 wk Range
0.315-1.74
Volume
65.14K
Average Volume (3m)
214.04K
1-Year Change
-65%
Book Value / Share
0.24
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ONVO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Organovo Holdings Inc Company Profile

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company’s lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Organovo Holdings, Inc. has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was incorporated in 2007 and is headquartered in San Diego, California.

Compare ONVO to Peers and Sector

Metrics to compare
ONVO
Peers
Sector
Relationship
P/E Ratio
−0.4x−3.0x−0.6x
PEG Ratio
−0.01−0.030.00
Price/Book
1.5x0.8x2.6x
Price / LTM Sales
52.2x7.4x3.1x
Upside (Analyst Target)
-403.0%52.1%
Fair Value Upside
Unlock15.1%8.2%Unlock

Earnings

Latest Release
Nov 07, 2024
EPS / Forecast
-0.14 / -0.26
Revenue / Forecast
30.00K / 41.00K
EPS Revisions
Last 90 days

People Also Watch

0.635
SGBX
-45.69%
3.36
IBRX
+1.51%
2.3100
SNGX
-1.70%
0.336
ERNA
0.00%
3.330
BLRX
-4.58%

FAQ

What Is the Organovo Holdings (ONVO) Stock Price Today?

The Organovo Holdings stock price today is 0.35

What Stock Exchange Does Organovo Holdings Trade On?

Organovo Holdings is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Organovo Holdings?

The stock symbol for Organovo Holdings is "ONVO."

What Is the Organovo Holdings Market Cap?

As of today, Organovo Holdings market cap is 5.37M.

What is Organovo Holdings Earnings Per Share?

The Organovo Holdings EPS is -0.968.

What Is the Next Organovo Holdings Earnings Date?

Organovo Holdings will release its next earnings report on Feb 11, 2025.

From a Technical Analysis Perspective, Is ONVO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.